Required Minimum Distribution (RMD)

Required Minimum Distribution (RMD) refers to the minimum amount that eligible individuals must withdraw from their employer-sponsored 401(k) plans annually after reaching a certain age, as mandated by the Internal Revenue Service (IRS) guidelines. The purpose of RMD is to ensure that retirement savings in tax-advantaged accounts, like 401(k)s, are not perpetually deferred, but rather, are gradually distributed during retirement to facilitate tax revenue collection.

 

Once an individual reaches the age of 72, they are generally required to begin taking RMDs from their employer 401(k) account. The RMD amount is calculated based on the individual's life expectancy and the account balance at the end of the previous year. Failure to withdraw the required amount may result in significant tax penalties.

 

  • Example 1: Sarah turned 72 last year and needs to start taking RMDs from her employer 401(k) plan. Her account balance at the end of the previous year was $500,000, and her life expectancy factor is 25. Based on this, her RMD for the current year would be $20,000 ($500,000 ÷ 25).

  • Example 2: John inherited a 401(k) account from his late father. As a non-spouse beneficiary, he must take RMDs based on his own life expectancy, determined by IRS Single Life Expectancy Table. This means John needs to calculate his RMDs differently from a regular account holder.

  • Example 3: David, who is still working at age 72, participates in his employer's 401(k) plan. However, he doesn't need to take RMDs from that specific plan until he retires, provided he doesn't own 5% or more of the company. This exception allows him to continue contributing while postponing RMDs until retirement.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.